High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer

Beyer, S; Müller, L; Mitter, S; Keilmann, L; Meister, S; Buschmann, C; Kraus, F; Topalov, NE; Czogalla, B; Trillsch, F; Burges, A; Mahner, S; Schmoeckel, E; Löb, S; Corradini, S; Kessler, M; Jeschke, U; Kolben, T

Jeschke, U (通讯作者),Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Obstet & Gynecol, Munich, Germany.;Jeschke, U (通讯作者),Univ Hosp Augsburg, Dept Obstet & Gynecol, Augsburg, Germany.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023; 149 (8): 4293

Abstract

Purpose Endometrial cancer is the most common gynecological malignancy. The helicase RIG-I, a part of the innate immune system, and EFTUD2, a splicing......

Full Text Link